# Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI)

> **NCT00827788** · PHASE4 · COMPLETED · sponsor: **Ospedale San Donato** · enrollment: 432 (estimated)

## Conditions studied

- Contrast Induced Nephropathy
- Acute Myocardial Infarction

## Interventions

- **DRUG:** Iodixanol
- **DRUG:** Iopromide

## Key facts

- **NCT ID:** NCT00827788
- **Lead sponsor:** Ospedale San Donato
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2010-04
- **Final completion:** —
- **Target enrollment:** 432 (ESTIMATED)
- **Last updated:** 2010-11-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00827788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00827788, "Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00827788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*